Olympus Corporation of the Americas | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Modified SOLTIVE Study	Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Kidney Calculi, Male Urogenital Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Urinary Calculi, Urogenital Diseases, benign prostatic hyperplasia, kidney disorder, male reproductive system disorder, nephrolithiasis, prostate disorder, urinary system disorder, urolithiasis	Not yet recruiting	Not stated	2026-10-05		NCT07838077
Post-Market Study to Assess iTind Safety in Comparison to UroLift	Genital Diseases, Male Urogenital Diseases, Urogenital Diseases, benign prostatic hyperplasia, male reproductive system disorder, prostate disorder	Recruiting	Not applicable	2026-09-29		NCT04757116
STRIVE Post-Market Registry Study	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, pulmonary emphysema, respiratory system disorder	Recruiting	Not stated	2026-08-03		NCT04302272
The HANAROSTENT® Multi-Hole™ Biliary Stent is Indicated for Use in the Palliative Treatment of Biliary Strictures Produced by Malignant Neoplasms and the Study is to Demonstrate Clinical Safety and Performance of the Multi-Hole™ Stent for the Palliative Treatment of Malignant Biliary Obstruction.	Biliary Strictures Caused by Malignant Neoplasms	Not yet recruiting	Not applicable	2026-07-21		NCT07715240
Endoscopic Ultrasound Shear Wave Elastography Study	Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease	Recruiting	Not stated	2025-09-15		NCT06592820